Report Detail
Global Glucagon Market Growth 2019-2024
- RnM2996317 |
- 21 February, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.
Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and other field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.
North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Glucagon market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 620 million by 2024, from US$ 430 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Glucagon business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Glucagon market by product type, application, key manufacturers and key regions and countries.
This study considers the Glucagon value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Inject Glucagon
Nasal Glucagon
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Glucagon consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Glucagon market by identifying its various subsegments.
Focuses on the key global Glucagon manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Glucagon with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Glucagon submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Glucagon Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Glucagon Consumption 2014-2024
- 2.1.2 Glucagon Consumption CAGR by Region
- 2.2 Glucagon Segment by Type
- 2.2.1 Inject Glucagon
- 2.2.2 Nasal Glucagon
- 2.3 Glucagon Consumption by Type
- 2.3.1 Global Glucagon Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Glucagon Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Glucagon Sale Price by Type (2014-2019)
- 2.4 Glucagon Segment by Application
- 2.4.1 Emergency Kits
- 2.4.2 General Use
- 2.4.3 Diagnostic & Motility
- 2.4.4 Cardiogenic Shock
- 2.4.5 Others
- 2.5 Glucagon Consumption by Application
- 2.5.1 Global Glucagon Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Glucagon Value and Market Share by Application (2014-2019)
- 2.5.3 Global Glucagon Sale Price by Application (2014-2019)
3 Global Glucagon by Players
- 3.1 Global Glucagon Sales Market Share by Players
- 3.1.1 Global Glucagon Sales by Players (2017-2019)
- 3.1.2 Global Glucagon Sales Market Share by Players (2017-2019)
- 3.2 Global Glucagon Revenue Market Share by Players
- 3.2.1 Global Glucagon Revenue by Players (2017-2019)
- 3.2.2 Global Glucagon Revenue Market Share by Players (2017-2019)
- 3.3 Global Glucagon Sale Price by Players
- 3.4 Global Glucagon Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Glucagon Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Glucagon Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Glucagon by Regions
- 4.1 Glucagon by Regions
- 4.1.1 Global Glucagon Consumption by Regions
- 4.1.2 Global Glucagon Value by Regions
- 4.2 Americas Glucagon Consumption Growth
- 4.3 APAC Glucagon Consumption Growth
- 4.4 Europe Glucagon Consumption Growth
- 4.5 Middle East & Africa Glucagon Consumption Growth
5 Americas
- 5.1 Americas Glucagon Consumption by Countries
- 5.1.1 Americas Glucagon Consumption by Countries (2014-2019)
- 5.1.2 Americas Glucagon Value by Countries (2014-2019)
- 5.2 Americas Glucagon Consumption by Type
- 5.3 Americas Glucagon Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Glucagon Consumption by Countries
- 6.1.1 APAC Glucagon Consumption by Countries (2014-2019)
- 6.1.2 APAC Glucagon Value by Countries (2014-2019)
- 6.2 APAC Glucagon Consumption by Type
- 6.3 APAC Glucagon Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Glucagon by Countries
- 7.1.1 Europe Glucagon Consumption by Countries (2014-2019)
- 7.1.2 Europe Glucagon Value by Countries (2014-2019)
- 7.2 Europe Glucagon Consumption by Type
- 7.3 Europe Glucagon Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Glucagon by Countries
- 8.1.1 Middle East & Africa Glucagon Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Glucagon Value by Countries (2014-2019)
- 8.2 Middle East & Africa Glucagon Consumption by Type
- 8.3 Middle East & Africa Glucagon Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Glucagon Distributors
- 10.3 Glucagon Customer
11 Global Glucagon Market Forecast
- 11.1 Global Glucagon Consumption Forecast (2019-2024)
- 11.2 Global Glucagon Forecast by Regions
- 11.2.1 Global Glucagon Forecast by Regions (2019-2024)
- 11.2.2 Global Glucagon Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Glucagon Forecast by Type
- 11.8 Global Glucagon Forecast by Application
12 Key Players Analysis
- 12.1 Novo Nordisk
- 12.1.1 Company Details
- 12.1.2 Glucagon Product Offered
- 12.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novo Nordisk News
- 12.2 Eli Lilly
- 12.2.1 Company Details
- 12.2.2 Glucagon Product Offered
- 12.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Eli Lilly News
- 12.3 Fresenius Kabi
- 12.3.1 Company Details
- 12.3.2 Glucagon Product Offered
- 12.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Fresenius Kabi News
- 12.4 Torrent Labs
- 12.4.1 Company Details
- 12.4.2 Glucagon Product Offered
- 12.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Torrent Labs News
- 12.5 Taj Pharmaceuticals
- 12.5.1 Company Details
- 12.5.2 Glucagon Product Offered
- 12.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Taj Pharmaceuticals News
- 12.6 Xeris Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Glucagon Product Offered
- 12.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Xeris Pharmaceuticals News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Glucagon . Industry analysis & Market Report on Glucagon is a syndicated market report, published as Global Glucagon Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Glucagon market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
